<?xml version="1.0" encoding="UTF-8"?>
<p id="p0075">Identification of ocular surface cellular receptors utilized by respiratory viruses has provided information as to the permissiveness of ocular tissue to infection with these agents [
 <xref rid="bib6" ref-type="bibr">6</xref>,
 <xref rid="bib36" ref-type="bibr">36</xref>]. Central to COVID-19 pathogenicity is that cellular entry is via the cell surface angiotensin converting enzyme 2 (ACE2) receptor [
 <xref rid="bib37" ref-type="bibr">37</xref>,
 <xref rid="bib38" ref-type="bibr">38</xref>]. It is the only mammalian group I coronavirus known to use ACE2 as its receptor [
 <xref rid="bib39" ref-type="bibr">39</xref>]. ACE2 was previously identified as the receptor for SARS-Cov and NL63 [
 <xref rid="bib40" ref-type="bibr">40</xref>]. Virus infectivity studies have shown that ACE2 is essential for SARS-CoV-2 to enter HeLa cells [
 <xref rid="bib41" ref-type="bibr">41</xref>].
</p>
